Halogenation affects protein-ligand binding energies in drug design, suggesting implications for ADME properties.
Halogenation is a widely used strategy in drug design, not only to improve ADME properties but also because halogens can engage in halogen bonds (XBs) with biological targets. To predict...
No takes yet. Share an insight, caveat, or question.
Fortuna et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: